News
Novavax Inc. closed 73.72% short of its 52-week high of $23.86, which the company achieved on June 6th.
Zacks Investment Research on MSN13h
ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?We expect ANI Pharmaceuticals ANIP to surpass expectations when it reports first-quarter 2025 results on May 9, before market ...
Zacks Investment Research on MSN15h
Perrigo to Report Q1 Earnings: Is a Beat in Store for the Stock?We expect Perrigo Company plc PRGO to surpass expectations when it reports first-quarter 2025 earnings on May 7, before the ...
Novavax (NASDAQ:NVAX) has updated the terms of the previously announced collaboration and licensing agreement with Takeda (TAK).
Novavax, Inc. (Nasdaq: NVAX) has updated the terms of the previously announced collaboration and licensing agreement (CLA) ...
Novavax, Inc. (NVAX) said it has updated the terms of the collaboration and licensing agreement with Takeda. The company noted that the improved financial terms of the amended ...
We expect Novavax NVAX to surpass expectations when it reports first-quarter 2025 earnings on May 8, before the opening bell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback